G

Galderma Group AG
SIX:GALD

Watchlist Manager
Galderma Group AG
SIX:GALD
Watchlist
Price: 86.74 CHF 1.87% Market Closed
Market Cap: 20.6B CHF
Have any thoughts about
Galderma Group AG?
Write Note

Operating Margin
Galderma Group AG

14.8%
Current
12%
Average
7.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.8%
=
Operating Profit
607.8m
/
Revenue
4.1B

Operating Margin Across Competitors

Country CH
Market Cap 20.6B CHF
Operating Margin
15%
Country CA
Market Cap 559.6B CAD
Operating Margin N/A
Country US
Market Cap 93.2B USD
Operating Margin
1%
Country US
Market Cap 510.7k CAD
Operating Margin N/A
Country NL
Market Cap 84.9B Zac
Operating Margin
61%
Country IN
Market Cap 1.7B INR
Operating Margin
4%
Country ID
Market Cap 690.7T IDR
Operating Margin
38%
Country US
Market Cap 41.1B EUR
Operating Margin
1%
Country US
Market Cap 25.3B USD
Operating Margin
-54%
Country IN
Market Cap 2T INR
Operating Margin
68%
Country US
Market Cap 22B USD
Operating Margin
-5%
No Stocks Found

Galderma Group AG
Glance View

Market Cap
20.6B CHF
Industry
N/A

Galderma Group AG is a global leader in dermatology, committed to delivering innovative solutions that enhance the health and beauty of skin. Founded in 1981, the company has cultivated a rich portfolio of products spanning prescription medications and consumer skin health brands. It operates under key brands like Restylane, used for aesthetic solutions, and Cetaphil, known for its gentle skincare products. With a strong emphasis on research and development, Galderma consistently invests in cutting-edge technologies and clinical advancements to meet the diverse needs of its patients and consumers worldwide. As the skin health market continues to expand—driven by increasing awareness of skin conditions and the rise in demand for aesthetic treatments—Galderma is strategically positioned to capture significant growth opportunities. The company's proactive approach to sustainability and focus on patient-centric solutions further solidify its reputation in the industry. For investors, Galderma represents not just a steady performer in the healthcare sector, but also an innovative player navigating the evolving landscape of dermatology. By prioritizing both efficacy and consumer satisfaction, Galderma is not only promoting healthier skin but is also capitalizing on a rapidly growing market—making it a compelling addition to any investment portfolio.

GALD Intrinsic Value
Not Available
G

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.8%
=
Operating Profit
607.8m
/
Revenue
4.1B
What is the Operating Margin of Galderma Group AG?

Based on Galderma Group AG's most recent financial statements, the company has Operating Margin of 14.8%.